http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60476c327a78a0ce2aefb483cfe378d5
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hynes |
| name | Richard O. Hynes Richard O Hynes |
| given-name | Richard O. Richard O |
| organization-name | 1 Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA Howard Hughes Medical Institute and; *David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142 *Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; ‡Department of Biophysics, Faculty of Science, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto, 60601, Japan; §Departments of Obstetrics and Gynecology; and ‖Molecular and Cellular Engineering, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 Howard Hughes Medical Institute,; Koch Institute for Integrative Cancer Research,; Department of Biology, and Center for the Study of Hepatitis C, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.; Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Departments of Immunology and Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Center for Cancer Research, Massachusetts Institute of Technology, Cambridge Howard Hughes Medical Institute, Center for Cancer Research, and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and Whitehead Institute for Biomedical Research, Cambridge, MA 02142 Howard Hughes Medical Institute 2 , Department of Biology , , Cambridge, Massachusetts 02139, USA; Massachusetts Institute of Technology 2 , Department of Biology , , Cambridge, Massachusetts 02139, USA Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building E17, Room 227, Cambridge, MA 02139; and Center for Blood Research and Department of Pathology, Harvard Medical School, 800 Huntington Avenue, Boston, MA 02115 1 Howard Hughes Medical Institute and the Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge MA; Howard Hughes Medical Institute Department of Biology Massachusetts Institute of Technology Cambridge MA From the Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, MA; the Roon Research Center for Arteriosclerosis and Thrombosis, The Scripps Research Institute, La Jolla, CA; and the Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA. David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States *Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and From the Departments of Laboratory Medicine and Pathobiology, Medicine, and Pharmacology, University of Toronto, ON, Canada; The Canadian Blood Services, Ottawa, ON, Canada; The Toronto Platelet Immunobiology Group, St Michael's Hospital, Toronto, ON, Canada; and the Department of Biology, Howard Hughes Medical Institute and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA. The Center for Blood Research and Departments of Pathology and Medicine, Harvard Medical School, Boston, MA 02115; and Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 2Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts. 1 Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; 2 Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge,3 Massachusetts Glycobiology Research and Training Center and the Cancer Center, Departments of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0687; and Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139-6403 Center for Cancer Research, Massachusetts Institute of Technology, 40 Ames Street, E17-227, Cambridge, MA 02139, USA 2 Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, MIT, Cambridge, MA 02139, USA From the Howard Hughes Medical Institute, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA. Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139; Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; and Department of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center and Cancer Center, University of California at San Diego, La Jolla, CA 92093 Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA Howard Hughes Medical Institute, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA. *Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305; and ‡Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Howard Hughes Medical Institute and; Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; 1Howard Hughes Medical Institute, Center for Cancer Research, and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139;; Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139; Department of Molecular, Cell, and Developmental Biology and Molecular Biology Institute, University of California, Los Angeles, CA 90095-1570; Jonsson Comprehensive Cancer Center, Department of Obstretics and Gynecology, University of California, Los Angeles, CA 90095; Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical... David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139;; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139 Howard Hughes Medical Instilute, Center for Cancer Research, Department of Biology, Massachusetts lnstitute of Technology, Cambridge, MA, USA The author is a Howard Hughes Medical Institute Investigator at the Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot, Israel Howard Hughes Medical Institute and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 1Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 Koch Institute for Integrative Cancer Research and Department of Biology Massachusetts Institute of Technology Cambridge Massachusetts USA; Howard Hughes Medical Institute Massachusetts Institute of Technology Cambridge Massachusetts USA Howard Hughes Medical Institute and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139 Koch Institute, Biology Department, Massachusetts Institute of Technology, Cambridge Howard Hughes Medical Institute, Center for Cancer Research, MIT, Cambridge,MA, USA Richard O. Hynes is the Daniel K. Ludwig Professor for Cancer Research and Howard Hughes Medical Institute Investigator at the Koch Institute for Integrative Cancer Research, the Massachusetts Institute of Technology, Cambridge, MA. Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, University of Wisconsin, Madison, WI 53706; Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 Howard Hughes Medical Institute 1 , Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Center for Cancer Research 2 , Massachusetts Institute of Technology, Cambridge, MA 02139, USA 1Howard Hughes Medical Institute, Center for Cancer Research;; 2Department of Biology, Massachusetts Institute of Technology, Cambridge; and Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA Department of Biology, Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Howard Hughes Medical Institute,; Koch Institute for Integrative Cancer Research, and; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 aHoward Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 20139 From the Department of Molecular Genetics and Microbiology, Center for Platelet Function Studies/Department of Pediatrics, and Department of Pathology, University of Massachusetts Medical School, Worcester, MA; Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT; and Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA. Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA From the *Harvard Skin Disease Research Center, Division of Dermatology, Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, Massachusetts 02115; ‡MatTek Corporation, Ashland, Massachusetts 01721; the §Center for Cancer Research, Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 01239; and the ‖Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115 *Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; Howard Hughes Medical Institute, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, E17-227, MIT, Cambridge, MA 02139, USA. Authors' Affiliation: Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States From the Departments of Pathology and Internal Medicine and the Howard Hughes Medical Institute at The University of Michigan Medical Center, Ann Arbor, MI; the Center for Cancer Research, the Department of Biology, and the Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA; and The Center for Blood Research, and the Department of Pathology, Harvard Medical School, Boston, MA. 2 Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA *Howard Hughes Medical Institute, Massachusetts Institute of Technology Center for Cancer Research, Cambridge, MA 02139;; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts *Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; ‡Division of Nephrology and Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115 Authors' Affiliations: Departments of 1Biomedical Genetics, 2Dermatology, and 3Pediatrics and Environmental Medicine, University of Rochester Medical Center, Rochester, New York; and 4Howard Hughes Medical Institute and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Howard Hughes Medical Institute and Department of Medicine, School of Medicine, University of California at San Diego, La Jolla, CA 92093-0648; and Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139-4307 3Center for Cancer Research; 4Department of Biology, Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA *Howard Hughes Medical Institute, Center for Cancer Research, and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; ‡Divisions of Nephrology and Newborn Medicine, Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115; and §Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Howard Hughes Medical Institute, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; and 1David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts.; 4Department of Biology, MIT, Cambridge, Massachusetts.; 5Howard Hughes Medical Institute, Chevy Chase, Maryland. 2Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.; 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; 5Howard Hughes Medical Institute Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts. 4Massachusetts Institute of Technology, David Koch Institute for Integrated Cancer Biology, Cambridge, Massachusetts.; 5Howard Hughes Medical Institute, Chevy Chase, Maryland. Howard Hughes Medical Institute, Massachusetts Institute of Technology Boston Massachusetts USA From *The Center for Blood Research, the ‡Department of Pathology, and the §Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; ‖Millenium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139; and the ¶Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 From the Vascular Research Division, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of Pediatric Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA; and Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA. *Center for Blood Research, §Brigham and Women's Hospital, and ‡Department of Pathology and ‖Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; and **Howard Hughes Medical Institute and ¶Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; *Center for Blood Research, §Brigham and Women's Hospital, and ‡Department of Pathology and ‖Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; and **Howard Hughes Medical Institute and ¶Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, USA Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA (P.A.M., N.J., A.M.D.R., S.B., R.O.H.).; Howard Hughes Medical Institute, Chevy Chase, MD (S.B., R.O.H.). *Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; ‡Department of Veterans Affairs and Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305; §Department of Pathology, Tufts University Schools of Medicine and Veterinary Medicine, Boston, Massachusetts 02111; and ‖Department of Cell Biology and Anatomy, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 Department of Biology, Massachusetts Institute of Technology, Cambridge 02139, and Marine Biological Laboratory, Woods Hole, Massachusetts Howard Hughes Medical Institute, David H. Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts Howard Hughes Medical Institute , Center for Cancer Research, and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA Howard Hughes Medical Institute, Center For Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139 1Howard Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge; Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139 From the Imperial Cancer Research Fund, Lincoln's Inn Fields, London, England From the CBR Institute for Biomedical Research (J.M., A.K.C., B.C., V.S.D., C.L.P., D.D.W.)and Department of Pathology (J.M., A.K.C., B.C., V.S.D., D.D.W.), Harvard Medical School, Boston; and Howard Hughes Medical Institute (S.A., R.O.H.), Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge. Howard Hughes Medical Institute and Center for Cancer Research 5 , Department of Biology , , Cambridge, MA 02139, USA; Massachusetts Institute of Technology 5 , Department of Biology , , Cambridge, MA 02139, USA Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, MA 02115; Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and Department of Molecular Medicine, Max Planck Institute for Biochemistry, 82152 Martinsried, Germany The David H. Koch Institute for Integrative Cancer Research 1 , 2 , and 3; Department of Biology 1 , 2 , and 3; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 1 , 2 , and 3; The David H. Koch Institute for Integrative Cancer Research 1 , 2 , and 3; Department of Biology 1 , 2 , and 3; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 1 , 2 , and 3; Howard Hughes Medical Institute, Chevy Chase, MD 20815 4 Howard Hughes Medical Institute, Center for Cancer Research , Cambridge, Massachusetts 02139, USA From the Center for Blood Research, Departments of Pathology and Medicine, Harvard Medical School, Boston; Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; and Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI. *Howard Hughes Medical Institute, Center for Cancer Research, ‡Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; §Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115; and ‖Onyx Pharmaceuticals, 3031 Research Drive, Richmond, California 94806; *Howard Hughes Medical Institute, Center for Cancer Research, ‡Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; §Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115; and ‖Onyx Pharmaceuticals, 3031 Research Drive, Richmond, California 94806 Imperial Cancer Research Fund, Lincoln's Inn Fields, London, WC2A 3PX, England Howard Hughes Medical Institute, Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA From the Cardiovascular Research Group (S.E.F.), University of Sheffield, Sheffield, UK; the Centre for Human Genetics (M.S., D.D.), University of Edinburgh, Edinburgh, UK; the Imperial Cancer Research Fund (K.H.-D.), St Thomas’ Hospital, London, UK; and the Howard Hughes Medical Institute (K.L.G., K.H.-D., B.L.B., R.O.H.), Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge. |
Incoming Links
Total number of triples: 373.